DUBLIN--(BUSINESS WIRE)--The "In Vitro Diagnostics (IVD) Quality Control Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023" report has been added to Research and Markets' offering.
The study on In Vitro Diagnostics (IVD) Quality Control Market covers the analysis of global as well as regional markets such as North America, Europe, Asia Pacific, and Rest of the World. According to the report the In Vitro Diagnostics (IVD) Quality Control Market is expected to grow at a CAGR between 3.0% and 3.5% over the forecast period 2017-2023.
The report on Global In Vitro Diagnostics (IVD) Quality Control Market is a comprehensive study of demand, market size, forecasts, trends and factors affecting the Global In Vitro Diagnostics (IVD) Quality Control Market. Moreover, the report is collective presentation of primary and secondary research findings.
Companies Mentioned
- Roche Diagnostics
- Thermo Fisher Scientific Inc.
- Helena Laboratories
- Randox Laboratories Ltd.
- Seracare Life Sciences, Inc.
- Sero as
- Technopath Clinical Diagnostics
- Ortho Clinical Diagnostics, Inc.
- Abbott Laboratories Inc.
- Bio-Rad Laboratories, Inc.
Key Topics Covered:
1. Preface
2. Executive summary
3. Global In Vitro Diagnostics (IVD) Quality Control Market Overview
4. Snapshots
5. Global In Vitro Diagnostics (IVD) Quality Control Market analysis, by Products and Services (USD million) 2017-2023
6. Global In Vitro Diagnostics (IVD) Quality Control Market analysis, by Application (USD million) 2017-2023
7. Global In Vitro Diagnostics (IVD) Quality Control Market analysis, by Manufacturer Type (USD million) 2017-2023
8. Global In Vitro Diagnostics (IVD) Quality Control Market analysis, by End User (USD million) 2017-2023
9. Global In Vitro Diagnostics (IVD) Quality Control Market analysis, regional analysis (USD million) 2017-2023
10. Company profiles
For more information about this report visit https://www.researchandmarkets.com/research/ml4j5v/in_vitro
